您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (1): 83-87.doi: 10.6040/j.issn.1671-7554.0.2020.1148

• 临床医学 • 上一篇    下一篇

隐匿性甲状腺癌:1例病例报道和文献回顾

柴佳威1,朱坤兵1,李亚琼2,王甜甜3   

  1. 1. 山东大学附属山东省妇幼保健院乳腺甲状腺外科, 山东 济南 250014;2. 山东第一医科大学附属山东省立医院病理科, 山东 济南 250021;3. 山东第一医科大学附属山东省立医院乳腺甲状腺外科, 山东 济南 250021
  • 发布日期:2021-01-09
  • 通讯作者: 王甜甜. E-mail:wangtiantian1981@hotwail.com
  • 基金资助:
    山东省医药卫生科技发展计划(2017ws098)

Occult thyroid carcinoma: a report of a rare case and review of literature

CHAI Jiawei1, ZHU Kunbing1, LI Yaqiong2, WANG Tiantian3   

  1. 1. Department of Breast and Thyroid Surgery, Shandong Maternity and Child Care Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China;
    2. Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China;
    3. Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2021-01-09

PDF (PC)

317

摘要： 目的 探讨隐匿性甲状腺癌病灶隐匿的可能原因,分析隐匿性甲状腺癌的临床特点及相关的治疗方式。 方法 对我科1例隐匿性甲状腺癌(中央区淋巴结查见甲状腺癌病灶,而甲状腺癌病理未证实原发灶)患者进行病例讨论,并通过文献复习,分析总结隐匿性甲状腺癌的病灶可能的隐匿原因、分类、诊断及治疗。 结果 经分析病例并文献检索,隐匿性甲状腺癌常见病灶隐匿原因:异位甲状腺组织的恶变、病理检测手段的局限、癌细胞的退行性改变。隐匿性甲状腺癌诊断相对困难,需综合应用多元化诊断手段来提高确诊率,治疗方式为以手术为主的综合治疗。本例患者随访20个月,无疾病进展。 结论 了解各类隐匿性甲状腺癌的临床特征、病灶可能的隐匿原因、诊断方法、以及手术方式,可以提高隐匿性甲状腺癌的确诊率并改善预后。

关键词: 隐匿性甲状腺癌, 临床分类, 诊断, 治疗

Abstract: Objective To explore the possible causes, clinical characteristics and treatment of occult thyroid carcinoma. Methods The clinical data of a case of occult thyroid carcinoma treated in our department were retrospectively analyzed and literature was reviewed. The etiology, classification, diagnosis and treatment of this rare disease were summarized. Results The possible causes of occult thyroid carcinoma included malignant transformation of ectopic thyroid tissues, limitations of pathological detection and degenerative changes of cancer cells. This disease was difficult to diagnose, and comprehensive methods were necessary to establish the diagnosis. Surgery was the major treatment. During the follow-up of 20 months, there was no disease progression in this case. Conclusion Understanding the clinical features, possible causes, diagnostic methods and surgical methods of all subtypes of occult thyroid carcinoma can improve the diagnosis rate and prognosis.

Key words: Occult thyroid cancer, Clinical classification, Diagnosis, Treatment

中图分类号: 

  • R736.1
[1] Yang GC, LiVolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up[J]. Int J Surg Pathol, 2002, 10(2): 133-139.
[2] Boucek J, Kastner J, Skrivan J, et al. Occult thyroid carcinoma[J]. Acta Otorhinolaryngol Ital,2009,29(6):296-304.
[3] Izzard M, McIvor N, Chaplin J, et al. Neurological deficit as a presentation of occult metastatic thyroid carcinoma[J]. ANZ J Surg, 2006, 76(10): 953-956.
[4] Yamamoto Y, Maeda T, Izumi K, et al. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases[J]. Cancer, 1990, 65(5): 1173-1179.
[5] Yuen AP, Ho AC, Wong BY. Ultrasonographic screening for occult thyroid cancer[J]. Head Neck, 2011, 33(4): 453-457.
[6] Kwak JY. Indications for fine needle aspiration in thyroid nodules[J]. Endocrinol Metab, 2013, 28(2): 81.
[7] Pardal-de-Oliveira F, Vieira F. Occult papillary carcinoma of the thyroid gland with extensive osseous metastases: a case report with review of the literature[J]. Pathol Res Pract, 1999, 195(10): 711-714.
[8] Cavazza A, Roggeri A, Zini M, et al. Lymphangioleiomyomatosis associated with pulmonary metastasis from an occult papillary carcinoma of the thyroid: report of a case occurring in a patient without tuberous sclerosis[J]. Pathol-Res Pract, 2002, 198(12): 825-828.
[9] Lecumberri B, Alvarez-Escolá C, Martín-Vaquero P, et al. Solitary hemorrhagic cerebellar metastasis from occult papillary thyroid microcarcinoma[J]. Thyroid, 2010,20(5):563-567.
[10] Kushwaha JK, Sonkar AA, Goel MM, et al. Papillary carcinoma of thyroid arising from ectopic thyroid tissue inside branchial cleft cyst: a rare case[J]. Case Rep, 2012, 2012(jul06 1): bcr0220125783.
[11] Xu JJ, Kwan K, Fung K. Papillary thyroid carcinoma in a lateral neck cyst: primary of ectopic thyroid tissue versus cystic metastasis[J]. J Laryngol Otol, 2013, 127(7): 724-727.
[12] Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature[J]. Int J Clin Exp Pathol, 2014,7(8):5210-5214.
[13] Herbowski L, Dobrzycki W. Incidental detection of unexpected neck lymphatic III level node metastasis from occult papillary thyroid carcinoma during cervical disc surgery: first literature report[J]. Endokrynologia Polska, 2020. doi:10.5603/ep.a2020.0031.
[14] Yamashita G, Kondo T, Okimura A, et al. Occult papillary thyroid carcinoma without detection of the primary tumor on preoperative ultrasonography or postoperative pathological examination: a case report[J]. Case Rep Oncol, 2020, 13(1): 105-112.
[15] Ito Y, Hirokawa M, Fukushima M, et al. Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultrasonography[J]. World J Surg, 2008, 32(9): 1955-1960.
[16] Yamamoto T, Tatemoto Y, Hibi Y, et al. Thyroid carcinomas found incidentally in the cervical lymph nodes: do they arise from heterotopic thyroid tissues?[J]. J Oral Maxillofac Surg, 2008, 66(12): 2566-2576.
[17] Liska J, Altanerova V, Galbavy S, et al. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer[J]. Endocr Regul, 2005, 39(3): 73-83.
[18] Ibrahim NBN, Milewski PJ, Gillett R, et al. Benign thyroid inclusions within cervical lymph nodes: an alarming incidental finding[J]. ANZ J Surg, 1981, 51(2): 188-189.
[19] Liska J, Altanerova V, Galbavy S, et al. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer[J]. Endocr Regul, 2005, 39(3): 73-83.
[20] Shinohara M, Harada T, Nakamura S, et al. Heterotopic salivary gland tissue in lymph nodes of the cervical region[J]. Int J Oral Maxillofac Surg, 1992, 21(3): 166-171.
[21] Ansari-Lari MA, Westra WH. The prevalence and significance of clinically unsuspected neoplasms in cervical lymph nodes[J]. Head Neck, 2003, 25(10): 841-847.
[22] Coleman SC, Smith JC, Burkey BB, et al. Long-standing lateral neck mass as the initial manifestation of well-differentiated thyroid carcinoma[J]. Laryngoscope, 2000, 110(2): 204.
[23] Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma[J]. Am J Clin Pathol, 2008, 130(5): 736-744.
[24] Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma[J]. Am J Surg Pathol, 2004, 28(10): 1336-1340.
[25] Kapur U, Wojcik EM. Follicular neoplasm of the thyroid: vanishing cytologic diagnosis?[J]. Diagn Cytopathol, 2007, 35(8): 525-528.
[26] Sako H, Abe H, Kodama M, et al. Histological study of minute papillary carcinoma of the thyroid[J].The journal of the Japanese Practical Surgeon Society, 2009. doi: 10.3919/ringe1963.57.2088.
[27] Khoo ML, Ezzat S, Freeman JL, et al. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification[J]. J Clin Endocrinol Metab, 2002, 87(4): 1810-1813.
[28] Lantsov D, Meirmanov S, Nakashima M, et al. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression[J]. Histopathology, 2005, 47(3): 248-256.
[29] Londero SC, Godballe C, Krogdahl A, et al. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?[J]. Acta Oncol, 2008, 47(3): 451-457.
[30] Zou M, Al-Baradie RS, Al-Hindi H, et al. S100A4(Mts1)gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma[J]. Br J Cancer, 2005, 93(11): 1277-1284.
[31] Min HS, Choe G, Kim S, et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid[J]. Mod Pathol, 2008, 21(6): 748-755.
[32] 刘永刚, 张蕾. 102例颈部肿块的临床分析[J]. 内蒙古医学杂志, 2012, 44(11): 1353-1354.
[33] Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature[J]. Int J Clin Exp Pathol, 2014,7(8):5210-5214.
[34] Medas F, Canu G, Cappellacci F, et al. Prophylactic central lymph node dissection improves disease-free survival in patients with intermediate and high risk differentiated thyroid carcinoma: a retrospective analysis on 399 patients[J]. Cancers, 2020, 12(6): 1658.
[35] Hughes DT, White ML, Miller BS, et al. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer[J]. Surgery, 2010, 148(6): 1100-1106.
[1] 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[2] 巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[3] 王欣，邢春燕，杨艳平. 血清磷酸丙酮酸水合酶检测对诊断侵袭性白念珠菌感染的临床价值[J]. 山东大学学报(医学版), 2209, 47(6): 92-94.
[4] 徐平 于国放 李霞. 不同类型甲状腺上动脉PSV对Graves病与桥本氏甲状腺炎鉴别诊断的价值[J]. 山东大学学报(医学版), 2209, 47(6): 62-64.
[5] 王丽慧,高敏,孔北华. 子宫血管肉瘤2例报告并文献复习[J]. 山东大学学报 (医学版), 2022, 60(9): 108-112.
[6] 韩靖,贾春玲. 肺癌患者胸外手术前治疗牙周基础疾病对预防术后肺炎发生的效果评价[J]. 山东大学学报 (医学版), 2022, 60(9): 113-118.
[7] 孙文雄,吴日超,郑贤静,李丽, 张友忠. 宫颈血管周上皮样细胞肿瘤1例[J]. 山东大学学报 (医学版), 2022, 60(9): 125-128.
[8] 吴瑞芳,李长忠. 女性生育力保护的现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 1-7.
[9] 王文静,刘博策,毕见海,霍然. 超声引导下平阳霉素联合聚桂醇硬化治疗94例囊性淋巴管畸形的疗效[J]. 山东大学学报 (医学版), 2022, 60(8): 72-78.
[10] 彭超,周应芳. 子宫腺肌病的药物治疗进展[J]. 山东大学学报 (医学版), 2022, 60(7): 20-25.
[11] 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
[12] 王福立,孙银萍,秦杰,荣建胜. DC-CIK细胞联合EGFR-TKI治疗35例老年晚期EGFR突变肺癌的效果[J]. 山东大学学报 (医学版), 2022, 60(7): 110-117.
[13] 查菁,郭婧,左秀丽. 少见类型肠梗阻病因病例报告1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 130-132.
[14] 宋敏,周玉侠,高璐,刘娜,王菊,古晋,张艳萍. 1例6 q三体嵌合胎儿的产前诊断[J]. 山东大学学报 (医学版), 2022, 60(5): 109-113.
[15] 王菊,高帅,范玉琛,王凯. 肝衰竭并发真菌感染综合治疗1例[J]. 山东大学学报 (医学版), 2022, 60(5): 125-128.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 高静,陈雯,张同霞,王小花,戴廷军,姚红,赵秀鹤,迟兆富,单培彦 . 颞叶癫痫大鼠海马线粒体细胞色素氧化酶亚基Ⅲ和Ⅳ表达的变化[J]. 山东大学学报(医学版), 2007, 45(8): 817 -820 .
[2] 肖伟玲,林亚杰,牟东珍,孙萍,梁淑娟 . 分泌型人IL-1β表达载体的构建及在H7402细胞中的表达[J]. 山东大学学报(医学版), 2008, 46(2): 119 -122 .
[3] 孙维彤,邹伟伟,李爱国,席延伟,张娜. 脂质体粒径对促进托氟啶口服吸收的影响[J]. 山东大学学报(医学版), 2007, 45(6): 639 -642 .
[4] . 干细胞标记物LGR5在结直肠癌发生发展中的表达及意义[J]. 山东大学学报(医学版), 2009, 47(8): 85 -88 .
[5] 于清梅,武玉玲,宋海岩,尹华伟,庄园 . p38丝裂原活化蛋白激酶在小鼠早期胚胎及围植入期子宫内膜的表达[J]. 山东大学学报(医学版), 2008, 46(2): 123 -127 .
[6] 于渊1,李岩1,荣风年2,梁婧1,刘晓琳1,王福立1. 自体CIK细胞治疗对卵巢癌调节性T细胞的影响[J]. 山东大学学报(医学版), 2010, 48(5): 101 -104 .
[7] 张勇,叶静,郭新星,肖水清. 牙周膜牵张成骨快速移动牙牙髓中IL-8表达的变化[J]. 山东大学学报(医学版), 2008, 46(4): 379 -381 .
[8] 林文俐1，张楠2，曲飞3，刘杰2，王婧男4，解田燕3，孙玉萍2. 肝细胞生长因子和血管内皮生长因子C在非小细胞肺癌中的共表达及与淋巴管生成的相关性[J]. 山东大学学报(医学版), 2010, 48(10): 111 -115 .
[9] 杨奎忠,孙雪飞,项继顺,杜庆聪,黄凤昌 . c-FLIP反义寡核苷酸对食管癌EC109细胞裸鼠移植瘤抑制作用的实验研究[J]. 山东大学学报(医学版), 2007, 45(12): 1234 -1238 .
[10] 俞新爽,韩俊庆,王兴文,盛巍,王瑜. 乳腺癌患者细胞免疫水平与预后危险因素的关系及临床意义[J]. 山东大学学报(医学版), 2007, 45(9): 934 -937 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发